SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $915,000 | +115.3% | 5,384 | +44.7% | 0.11% | +158.5% |
Q4 2019 | $425,000 | +62.2% | 3,721 | +21.3% | 0.04% | +105.0% |
Q3 2019 | $262,000 | +15.9% | 3,068 | -5.9% | 0.02% | +53.8% |
Q2 2019 | $226,000 | -82.6% | 3,261 | -81.6% | 0.01% | -82.2% |
Q1 2019 | $1,296,000 | -48.7% | 17,694 | -45.9% | 0.07% | -52.9% |
Q3 2018 | $2,524,000 | +341.3% | 32,733 | +199.7% | 0.16% | +400.0% |
Q1 2018 | $572,000 | +181.8% | 10,922 | +192.3% | 0.03% | +210.0% |
Q3 2017 | $203,000 | -54.3% | 3,736 | -59.2% | 0.01% | -75.0% |
Q2 2015 | $444,000 | – | 9,164 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |